Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology.
Brouillard, Franck, Fritsch, Janine, Edelman, Aleksander et al. · Proteomics. Clinical applications · 2008 · DOI
Quick Summary
This review article discusses cytokeratins, which are structural proteins found in cells throughout the body. Researchers used advanced laboratory techniques called proteomics to study how these proteins are involved in various diseases, including chronic fatigue syndrome (ME/CFS). The article summarizes what scientists have learned about cytokeratins' roles in disease and suggests these proteins might be useful targets for developing new treatments.
Why It Matters
This review is significant because it identifies cytokeratins as biomarkers associated with ME/CFS and suggests they may be involved in disease mechanisms. Understanding the molecular basis of ME/CFS through proteomics could lead to better diagnostic tools and potential therapeutic targets. The article highlights that proteomics techniques may help researchers uncover hidden cellular changes in ME/CFS patients.
Observed Findings
Proteomics has identified associations between cytokeratin expression or modification and chronic fatigue syndrome.
Cytokeratins are involved in multiple disease processes including inflammation, drug resistance, and response to infections.
Cytokeratins have been proposed as potential therapeutic targets in some diseases like cystic fibrosis.
Proteomics technology has been useful for uncovering new functions and disease associations of cytokeratins.
Cytokeratin changes are associated with stem cell differentiation, tissue repair, and embryo development.
Inferred Conclusions
Proteomics is a valuable tool for identifying disease-relevant changes in cytokeratin expression and modification.
Cytokeratins may represent biomarkers or therapeutic targets relevant to multiple diseases including ME/CFS.
A dedicated research field focusing specifically on cytokeratins as the primary research subject could advance understanding of their roles in disease.
Cytokeratins serve as both disease indicators and useful models for developing new proteomics technologies.
Remaining Questions
What are the specific mechanisms by which cytokeratin changes contribute to ME/CFS pathophysiology?
What This Study Does Not Prove
This review does not demonstrate that cytokeratins directly cause ME/CFS or establish the specific mechanisms by which they contribute to disease pathophysiology. The article cannot prove that measuring cytokeratins would be clinically useful for diagnosing or treating ME/CFS specifically, as it primarily synthesizes literature across multiple diseases. Causation cannot be inferred from descriptive associations mentioned in a narrative review.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →